Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Mechanistic Investigations of Diarrhea Toxicity Induced by anti-HER2/3 Combination Therapy.

Moisan A, Michielin F, Jacob W, Kronenberg S, Wilson S, Avignon B, Gérard R, Benmansour F, McIntyre C, Meneses-Lorente G, Hasmann M, Schneeweiss A, Weisser M, Adessi C.

Mol Cancer Ther. 2018 Apr 13. pii: molcanther.1268.2017. doi: 10.1158/1535-7163.MCT-17-1268. [Epub ahead of print]

PMID:
29654069
2.

Distinct clinical characteristics and helminth co-infections in adult tuberculosis patients from urban compared to rural Tanzania.

Sikalengo G, Hella J, Mhimbira F, Rutaihwa LK, Bani F, Ndege R, Sasamalo M, Kamwela L, Said K, Mhalu G, Mlacha Y, Hatz C, Knopp S, Gagneux S, Reither K, Utzinger J, Tanner M, Letang E, Weisser M, Fenner L.

Infect Dis Poverty. 2018 Mar 24;7(1):24. doi: 10.1186/s40249-018-0404-9.

3.

Structure of a eukaryotic cytoplasmic pre-40S ribosomal subunit.

Scaiola A, Peña C, Weisser M, Böhringer D, Leibundgut M, Klingauf-Nerurkar P, Gerhardy S, Panse VG, Ban N.

EMBO J. 2018 Apr 3;37(7). pii: e98499. doi: 10.15252/embj.201798499. Epub 2018 Feb 19.

PMID:
29459436
4.

Clostridium difficile infection is associated with graft loss in solid organ transplant recipients.

Cusini A, Béguelin C, Stampf S, Boggian K, Garzoni C, Koller M, Manuel O, Meylan P, Mueller NJ, Hirsch HH, Weisser M, Berger C, van Delden C; Swiss Transplant Cohort Study.

Am J Transplant. 2018 Jan 19. doi: 10.1111/ajt.14640. [Epub ahead of print]

PMID:
29349869
5.

Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer.

Schneeweiss A, Park-Simon TW, Albanell J, Lassen U, Cortés J, Dieras V, May M, Schindler C, Marmé F, Cejalvo JM, Martinez-Garcia M, Gonzalez I, Lopez-Martin J, Welt A, Levy C, Joly F, Michielin F, Jacob W, Adessi C, Moisan A, Meneses-Lorente G, Racek T, James I, Ceppi M, Hasmann M, Weisser M, Cervantes A.

Invest New Drugs. 2018 Jan 19. doi: 10.1007/s10637-018-0562-4. [Epub ahead of print]

PMID:
29349598
6.

Bone metabolism dynamics in the early post-transplant period following kidney and liver transplantation.

Schreiber PW, Bischoff-Ferrari HA, Boggian K, Bonani M, van Delden C, Enriquez N, Fehr T, Garzoni C, Hirsch HH, Hirzel C, Manuel O, Meylan P, Saleh L, Weisser M, Mueller NJ; Swiss Transplant Cohort Study (STCS).

PLoS One. 2018 Jan 16;13(1):e0191167. doi: 10.1371/journal.pone.0191167. eCollection 2018.

7.

Extracellular matrix content and WNT/β-catenin levels of cartilage determine the chondrocyte response to compressive load.

Praxenthaler H, Krämer E, Weisser M, Hecht N, Fischer J, Grossner T, Richter W.

Biochim Biophys Acta. 2018 Mar;1864(3):851-859. doi: 10.1016/j.bbadis.2017.12.024. Epub 2017 Dec 19.

PMID:
29277327
8.

89Zr-Lumretuzumab PET Imaging before and during HER3 Antibody Lumretuzumab Treatment in Patients with Solid Tumors.

Bensch F, Lamberts LE, Smeenk MM, Jorritsma-Smit A, Lub-de Hooge MN, Terwisscha van Scheltinga AGT, de Jong JR, Gietema JA, Schröder CP, Thomas M, Jacob W, Abiraj K, Adessi C, Meneses-Lorente G, James I, Weisser M, Brouwers AH, de Vries EGE.

Clin Cancer Res. 2017 Oct 15;23(20):6128-6137. doi: 10.1158/1078-0432.CCR-17-0311. Epub 2017 Jul 21.

9.

Structural and Functional Insights into Human Re-initiation Complexes.

Weisser M, Schäfer T, Leibundgut M, Böhringer D, Aylett CHS, Ban N.

Mol Cell. 2017 Aug 3;67(3):447-456.e7. doi: 10.1016/j.molcel.2017.06.032. Epub 2017 Jul 18.

PMID:
28732596
10.

Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy.

Cannarile MA, Weisser M, Jacob W, Jegg AM, Ries CH, Rüttinger D.

J Immunother Cancer. 2017 Jul 18;5(1):53. doi: 10.1186/s40425-017-0257-y. Review.

11.

Prevention of mother-to-child transmission of HIV Option B+ cascade in rural Tanzania: The One Stop Clinic model.

Gamell A, Luwanda LB, Kalinjuma AV, Samson L, Ntamatungiro AJ, Weisser M, Gingo W, Tanner M, Hatz C, Letang E, Battegay M; KIULARCO Study Group.

PLoS One. 2017 Jul 12;12(7):e0181096. doi: 10.1371/journal.pone.0181096. eCollection 2017.

12.

Cohort profile: The Kilombero and Ulanga Antiretroviral Cohort (KIULARCO) - A prospective HIV cohort in rural Tanzania.

Letang E, Kalinjuma AV, Glass TR, Gamell A, Mapesi H, Sikalengo GR, Luwanda LB, Mnzava D, Ntamatungiro AJ, Ndaki R, Francis G, Vanobberghen F, Furrer H, Klimkait T, Felger I, Tanner M, Hatz C, Weisser M, Battegay M, Kiularco Study Group.

Swiss Med Wkly. 2017 Jul 11;147:w14485. doi: 10.4414/smw.2017.14485. eCollection 2017 Jul 11.

13.

Projekt Notfallstation im St. Francis Referral Hospital, Ifakara, Tansania.

Rohacek M, Hatz C, Weisser M.

Praxis (Bern 1994). 2017 Jun;106(12):651-655. doi: 10.1024/1661-8157/a002698. German. No abstract available.

PMID:
28609245
14.

Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity.

Meulendijks D, Jacob W, Voest EE, Mau-Sorensen M, Martinez-Garcia M, Taus A, Fleitas T, Cervantes A, Lolkema MP, Langenberg MHG, De Jonge MJ, Sleijfer S, Han JY, Calles A, Felip E, Kim SW, Schellens JHM, Wilson S, Thomas M, Ceppi M, Meneses-Lorente G, James I, Vega-Harring S, Dua R, Nguyen M, Steiner L, Adessi C, Michielin F, Bossenmaier B, Weisser M, Lassen UN.

Clin Cancer Res. 2017 Sep 15;23(18):5406-5415. doi: 10.1158/1078-0432.CCR-17-0812. Epub 2017 Jun 9.

PMID:
28600476
15.

Accelerating drug development by efficiently using emerging PK/PD data from an adaptable entry-into-human trial: example of lumretuzumab.

Meneses-Lorente G, McIntyre C, Hsu JC, Thomas M, Jacob W, Adessi C, Weisser M.

Cancer Chemother Pharmacol. 2017 Jun;79(6):1239-1247. doi: 10.1007/s00280-017-3328-3. Epub 2017 May 11.

PMID:
28497320
16.

Direct estrogen receptor (ER) / HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer.

Collins D, Jacob W, Cejalvo JM, Ceppi M, James I, Hasmann M, Crown J, Cervantes A, Weisser M, Bossenmaier B.

PLoS One. 2017 May 11;12(5):e0177331. doi: 10.1371/journal.pone.0177331. eCollection 2017.

17.

HELM Software for Biopolymers.

Milton J, Zhang T, Bellamy C, Swayze E, Hart C, Weisser M, Hecht S, Rotstein S.

J Chem Inf Model. 2017 Jun 26;57(6):1233-1239. doi: 10.1021/acs.jcim.6b00442. Epub 2017 May 19.

PMID:
28471655
18.

Global chondrocyte gene expression after a single anabolic loading period: Time evolution and re-inducibility of mechano-responses.

Scholtes S, Krämer E, Weisser M, Roth W, Luginbühl R, Grossner T, Richter W.

J Cell Physiol. 2018 Jan;233(1):699-711. doi: 10.1002/jcp.25933. Epub 2017 May 19.

PMID:
28369921
19.

Secular trends of bloodstream infections during neutropenia in 15 181 haematopoietic stem cell transplants: 13-year results from a European multicentre surveillance study (ONKO-KISS).

Weisser M, Theilacker C, Tschudin Sutter S, Babikir R, Bertz H, Götting T, Dettenkofer M, Kern WV, Widmer AF; Hospital Infection Surveillance System for Patients With Haematologic/Oncologic Malignancies Study Group (ONKO-KISS).

Clin Microbiol Infect. 2017 Nov;23(11):854-859. doi: 10.1016/j.cmi.2017.03.020. Epub 2017 Mar 31.

PMID:
28366613
20.

Peptide-functionalized starPEG/heparin hydrogels direct mitogenicity, cell morphology and cartilage matrix distribution in vitro and in vivo.

Hesse E, Freudenberg U, Niemietz T, Greth C, Weisser M, Hagmann S, Binner M, Werner C, Richter W.

J Tissue Eng Regen Med. 2017 Jan 13. doi: 10.1002/term.2404. [Epub ahead of print]

PMID:
28083992
21.

Human MicroRNA Responses Predict Cytomegalovirus Replication Following Solid Organ Transplantation.

Han SH, Kumar D, Ferreira VH, Egli A, Hirsch HH, Weisser M, Garzoni C, van Delden C, Bochud PY, Manuel O, Meylan P, Boggian K, Husain S, Mueller NJ, Humar A; Swiss Transplant Cohort Study.

J Infect Dis. 2017 Feb 15;215(4):537-546. doi: 10.1093/infdis/jiw596.

PMID:
28003351
22.

Staphylococcus aureus Endocarditis as a Complication of Toxocariasis-Associated Endomyocarditis With Fibrosis: A Case Report.

Kuenzli E, Labhardt N, Balestra G, Weisser M, Zellweger MJ, Blum J.

Open Forum Infect Dis. 2016 Sep 7;3(3):ofw145. eCollection 2016 Sep.

23.

Association of daptomycin use with resistance development in Enterococcus faecium bacteraemia-a 7-year individual and population-based analysis.

Egli A, Schmid H, Kuenzli E, Widmer AF, Battegay M, Plagge H, Frei R, Achermann R, Weisser M.

Clin Microbiol Infect. 2017 Feb;23(2):118.e1-118.e7. doi: 10.1016/j.cmi.2016.10.003. Epub 2016 Oct 13.

24.

Impact of MALDI-TOF-MS-based identification directly from positive blood cultures on patient management: a controlled clinical trial.

Osthoff M, Gürtler N, Bassetti S, Balestra G, Marsch S, Pargger H, Weisser M, Egli A.

Clin Microbiol Infect. 2017 Feb;23(2):78-85. doi: 10.1016/j.cmi.2016.08.009. Epub 2016 Aug 26.

25.

Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections.

Héquet D, Kralidis G, Carrel T, Cusini A, Garzoni C, Hullin R, Meylan PR, Mohacsi P, Mueller NJ, Ruschitzka F, Tozzi P, van Delden C, Weisser M, Wilhelm MJ, Pascual M, Manuel O; Swiss Transplant Cohort Study (STCS).

BMC Infect Dis. 2016 Jul 8;16:321. doi: 10.1186/s12879-016-1658-0.

26.

Hyperinflammation in patients with chronic granulomatous disease leads to impairment of hematopoietic stem cell functions.

Weisser M, Demel UM, Stein S, Chen-Wichmann L, Touzot F, Santilli G, Sujer S, Brendel C, Siler U, Cavazzana M, Thrasher AJ, Reichenbach J, Essers MA, Schwäble J, Grez M.

J Allergy Clin Immunol. 2016 Jul;138(1):219-228.e9. doi: 10.1016/j.jaci.2015.11.028. Epub 2016 Feb 4.

PMID:
26853280
27.

Validation of a treatment algorithm for orthopaedic implant-related infections with device-retention-results from a prospective observational cohort study.

Tschudin-Sutter S, Frei R, Dangel M, Jakob M, Balmelli C, Schaefer DJ, Weisser M, Elzi L, Battegay M, Widmer AF.

Clin Microbiol Infect. 2016 May;22(5):457.e1-9. doi: 10.1016/j.cmi.2016.01.004. Epub 2016 Jan 20.

28.

Development and application of two independent real-time PCR assays to detect clinically relevant Mucorales species.

Springer J, Goldenberger D, Schmidt F, Weisser M, Wehrle-Wieland E, Einsele H, Frei R, Löffler J.

J Med Microbiol. 2016 Mar;65(3):227-34. doi: 10.1099/jmm.0.000218. Epub 2016 Jan 7.

PMID:
26743820
29.

Low-Dose Acetylsalicylic Acid Treatment and Impact on Short-Term Mortality in Staphylococcus aureus Bloodstream Infection: A Propensity Score-Matched Cohort Study.

Osthoff M, Sidler JA, Lakatos B, Frei R, Dangel M, Weisser M, Battegay M, Widmer AF.

Crit Care Med. 2016 Apr;44(4):773-81. doi: 10.1097/CCM.0000000000001554.

PMID:
26741577
30.

First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid Tumors.

Meulendijks D, Jacob W, Martinez-Garcia M, Taus A, Lolkema MP, Voest EE, Langenberg MH, Fleitas Kanonnikoff T, Cervantes A, De Jonge MJ, Sleijfer S, Soerensen MM, Thomas M, Ceppi M, Meneses-Lorente G, James I, Adessi C, Michielin F, Abiraj K, Bossenmaier B, Schellens JH, Weisser M, Lassen UN.

Clin Cancer Res. 2016 Feb 15;22(4):877-85. doi: 10.1158/1078-0432.CCR-15-1683. Epub 2015 Oct 13.

31.

Combination therapy for multidrug-resistant cytomegalovirus disease.

Stuehler C, Stüssi G, Halter J, Nowakowska J, Schibli A, Battegay M, Dirks J, Passweg J, Heim D, Rovo A, Kalberer C, Bucher C, Weisser M, Dumoulin A, Hirsch HH, Khanna N.

Transpl Infect Dis. 2015 Oct;17(5):751-5. doi: 10.1111/tid.12435. Epub 2015 Oct 3.

PMID:
26432076
32.

Gene expression of INPP5F as an independent prognostic marker in fludarabine-based therapy of chronic lymphocytic leukemia.

Palermo G, Maisel D, Barrett M, Smith H, Duchateau-Nguyen G, Nguyen T, Yeh RF, Dufour A, Robak T, Dornan D, Weisser M; REACH investigators.

Blood Cancer J. 2015 Oct 2;5:e353. doi: 10.1038/bcj.2015.82.

33.

Complementary Molecular Dynamics and X-ray Reflectivity Study of an Imidazolium-Based Ionic Liquid at a Neutral Sapphire Interface.

Brkljača Z, Klimczak M, Miličević Z, Weisser M, Taccardi N, Wasserscheid P, Smith DM, Magerl A, Smith AS.

J Phys Chem Lett. 2015 Feb 5;6(3):549-55. doi: 10.1021/jz5024493. Epub 2015 Jan 26.

PMID:
26261977
34.

Lower dose anti-thymocyte globulin for GvHD prophylaxis results in improved survival after allogeneic stem cell transplantation.

Binkert L, Medinger M, Halter JP, Heim D, Gerull S, Holbro A, Lengerke C, Weisser M, Passweg JR.

Bone Marrow Transplant. 2015 Oct;50(10):1331-6. doi: 10.1038/bmt.2015.148. Epub 2015 Jun 29.

PMID:
26121111
35.

Only a Touch of the Flu? The Simultaneous Manifestation of Acute Necrotizing Encephalopathy in Two Consanguineous Patients.

Bloch C, Suter B, Fischmann A, Gensicke H, Rüegg S, Weisser M.

Open Forum Infect Dis. 2015 Feb 2;2(2):ofv013. doi: 10.1093/ofid/ofv013. eCollection 2015 Apr.

36.

Travelling activity and travel-related risks after allogeneic haematopoietic stem cell transplantation - a single centre survey.

Hollenstein Y, Elzi L, Hatz C, Passweg J, Weisser M, Stöckle M, Halter JP, Egli A.

Swiss Med Wkly. 2015 May 29;145:w14136. doi: 10.4414/smw.2015.14136. eCollection 2015.

37.

The swiss transplant cohort study: lessons from the first 6 years.

Berger C, Bochud PY, Boggian K, Cusini A, Egli A, Garzoni C, Hirsch HH, Hoffmann M, Khanna N, Manuel O, Meylan P, Nadal D, van Delden C, Weisser M, Mueller NJ; Transplant Infectious Diseases Working Group, Swiss Transplant Cohort Study.

Curr Infect Dis Rep. 2015 Jun;17(6):486. doi: 10.1007/s11908-015-0486-5.

PMID:
25916997
38.

Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation and Association With Occurrence and Outcome of Invasive Aspergillosis.

Stuehler C, Kuenzli E, Jaeger VK, Baettig V, Ferracin F, Rajacic Z, Kaiser D, Bernardini C, Forrer P, Weisser M, Elzi L, Battegay M, Halter J, Passweg J, Khanna N.

J Infect Dis. 2015 Sep 15;212(6):959-67. doi: 10.1093/infdis/jiv143. Epub 2015 Mar 6.

PMID:
25748323
39.

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) directly from positive blood culture flasks allows rapid identification of bloodstream infections in immunosuppressed hosts.

Egli A, Osthoff M, Goldenberger D, Halter J, Schaub S, Steiger J, Weisser M, Frei R.

Transpl Infect Dis. 2015 Jun;17(3):481-7. doi: 10.1111/tid.12373. Epub 2015 May 19.

PMID:
25704776
40.

Is admission screening for Pseudomonas aeruginosa useful in haematologic patients? A prospective study with 1310 patients.

Sidler JA, Frei R, Tschudin-Sutter S, Dangel M, Battegay M, Weisser M, Passweg J, Widmer AF.

Clin Microbiol Infect. 2015 Jun;21(6):572.e1-3. doi: 10.1016/j.cmi.2015.02.004. Epub 2015 Feb 10.

41.

Performances of two different panfungal PCRs to detect mould DNA in formalin-fixed paraffin-embedded tissue: what are the limiting factors?

Babouee Flury B, Weisser M, Prince SS, Bubendorf L, Battegay M, Frei R, Goldenberger D.

BMC Infect Dis. 2014 Dec 18;14:692. doi: 10.1186/s12879-014-0692-z.

42.

First case of infective endocarditis caused by Helicobacter cinaedi.

Bartels H, Goldenberger D, Reuthebuch O, Vosbeck J, Weisser M, Frei R, Bättig V.

BMC Infect Dis. 2014 Nov 18;14:586. doi: 10.1186/s12879-014-0586-0.

43.

IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation.

Wójtowicz A, Gresnigt MS, Lecompte T, Bibert S, Manuel O, Joosten LA, Rüeger S, Berger C, Boggian K, Cusini A, Garzoni C, Hirsch HH, Weisser M, Mueller NJ, Meylan PR, Steiger J, Kutalik Z, Pascual M, van Delden C, van de Veerdonk FL, Bochud PY; Swiss Transplant Cohort Study (STCS); Swiss Transplant Cohort Study STCS.

J Infect Dis. 2015 May 15;211(10):1646-57. doi: 10.1093/infdis/jiu636. Epub 2014 Nov 14.

44.

Surgical and antimicrobial treatment of prosthetic vascular graft infections at different surgical sites: a retrospective study of treatment outcomes.

Erb S, Sidler JA, Elzi L, Gurke L, Battegay M, Widmer AF, Weisser M.

PLoS One. 2014 Nov 13;9(11):e112947. doi: 10.1371/journal.pone.0112947. eCollection 2014.

45.

Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis.

Vuichard D, Weisser M, Orasch C, Frei R, Heim D, Passweg JR, Widmer AF.

BMC Infect Dis. 2014 Nov 11;14:573. doi: 10.1186/s12879-014-0573-5.

46.

Infection of cardiovascular implantable electronic devices: detection with sonication, swab cultures, and blood cultures.

Rohacek M, Erne P, Kobza R, Pfyffer GE, Frei R, Weisser M.

Pacing Clin Electrophysiol. 2015 Feb;38(2):247-53. doi: 10.1111/pace.12529. Epub 2014 Nov 7.

PMID:
25377386
47.

Limitations in study on benefits of clindamycin.

Banderet-Uglioni F, Battegay M, Weisser M, Frei R, Widmer AF.

Clin Infect Dis. 2015 Jan 15;60(2):323. doi: 10.1093/cid/ciu825. Epub 2014 Oct 23. No abstract available.

PMID:
25344540
48.

[Propranolol therapy for periocular and orbital infantile haemangiomas].

Sterker I, Tegetmeyer H, Sorge I, Weißer M, Böhm R.

Klin Monbl Augenheilkd. 2014 Oct;231(10):971-9. doi: 10.1055/s-0034-1383088. Epub 2014 Oct 21. Review. German.

PMID:
25333232
49.

Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients.

Madic J, Kiialainen A, Bidard FC, Birzele F, Ramey G, Leroy Q, Rio Frio T, Vaucher I, Raynal V, Bernard V, Lermine A, Clausen I, Giroud N, Schmucki R, Milder M, Horn C, Spleiss O, Lantz O, Stern MH, Pierga JY, Weisser M, Lebofsky R.

Int J Cancer. 2015 May 1;136(9):2158-65. doi: 10.1002/ijc.29265. Epub 2014 Oct 23.

50.

Influence of IFNL3/4 polymorphisms on the incidence of cytomegalovirus infection after solid-organ transplantation.

Manuel O, Wójtowicz A, Bibert S, Mueller NJ, van Delden C, Hirsch HH, Steiger J, Stern M, Egli A, Garzoni C, Binet I, Weisser M, Berger C, Cusini A, Meylan P, Pascual M, Bochud PY; Swiss Transplant Cohort Study.

J Infect Dis. 2015 Mar 15;211(6):906-14. doi: 10.1093/infdis/jiu557. Epub 2014 Oct 9.

PMID:
25301956

Supplemental Content

Loading ...
Support Center